Global Biobetters Market: An Overview

The global biobetters market has been witnessing growing interest among drug manufacturers as method of constantly improving the efficacy and reducing the risk, particularly that of the risk of immunogenicity. Biosetters are made from existing peptides or protein-based therapeutics. Key parameters that are altered in the process are stability, affinity, and selectivity.

The key proposition behind the swelling investments in the biobetters is perhaps the low commercial risk that it entails. Moreover, the low cost of research and development relative to developing biologics is also a favorable factor for biopharmaceutical companies. Further, researchers have gained better understanding of various regulatory requirements for establishing bioequivalence with comparator and reference products. This has helped them to develop biosetters with high stability.

Advances in design of protein-based techniques have further driven the evolution of the biobetters market. Key product types include biobetters based on G-CSF, erythropoietin, interferon, insulin, monoclonal antibodies, and anti-haemophilic factor.

Get an Idea about the Offerings of Our Biobetters Market Report from this Brochure

Global Biobetters Market: Growth Dynamics

The pressing need for finding out a way to improve the safety and efficacy of biologics has made biobetters as a tough contender against biosimilars. Growing investment in developing therapeutic agents of higher efficacy and safety profiles for cancers and autoimmune diseases has shaped the growth dynamics of the biobetters market. Over the past few years, there have been concerted efforts in reducing the economic burden of these diseases. Expanding array of monoclonal antibodies has also made a positive bearing on the biobetters market. Growing incidence of chronic diseases such as chronic kidney disease and chemotherapy-induced anemia has also added to the expansion of the market.

Players and investors in the biobetters market are relentlessly focused on developing better model of the protein-ligand complex, to get a competitive edge. This is because such a model is characterized by reducing the experimental effort considerably. Biopharmaceuticals are seeking innovative approaches to validate the complex structures in developing better biobetters. Over the recent years in the evolution of the biobetters market, an assortment of biophysical and biochemical techniques emerged, thereby providing a strong impetus to its growth.

Global Biobetters Market: Notable Developments

Strategic mergers and acquisitions have come out as a key step in getting a strong foothold in the biobetters market. In addition, top players are diversifying their product portfolio to retain their stronghold in developed markets. Several players are looking to acquire smaller companies or get into strategic tie-ups with biopharmaceutical companies with promising drug pipelines for developing biobetters. Further, they are constantly focusing on expanding their technical expertise to improve biophysical and biochemical techniques employed in developing biobetters with less experimental efforts. A case in point is substantial adoption of PEGylation. They are also expanding efforts to bolster their understanding of regulatory approval pathways. Most companies have strengthened their efforts in developing rational design of biobetters through computational study of protein aggregation using advanced simulation techniques.

Expanding Operations in Future? To Get the Perfect Launch Ask for a Custom Biobetters Market Report

Some of the prominent players operating in the biobetters market are CSL Behring GmbH, Teva Pharmaceutical Industries Ltd., Novo Nordisk A/S, Porton Biopharma Limited, Sanofi SA, Merck & Co. Inc., F. Hoffmann-La Roche AG, Amgen Inc.,

Global Biobetters Market: Regional Outlook

Among the various key regions in the biobetters market, North America and Europe have shown a large potential. The region has seen a volley of investments from manufacturers to tap revenues from the emerging paradigm of this new drug class. Especially manufacturers of biosimilar consider this as a worthwhile investment. Regional players are benefitting from partnerships with globally prominent players in these regions. Moreover, growing body of research on developing better validation methods to meet the evolving regulatory landscape is also a robust factor catapulting these regions to play a higher role in the biobetters market in the coming years.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis. 

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Biobetters Market

Pre Book